Qube Research & Technologies (QRT)
ULBI icon

Qube Research & Technologies (QRT)’s Ultralife ULBI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,910
Closed -$134K – 3965
2025
Q2 		$134K Buy
+14,910
New +$88.4K ﹤0.01% 2987
2024
Q3 		– Sell
-2,174
Closed -$23.1K – 4144
2024
Q2 		$23.1K Sell
2,174
-24,100
-92% -$257K ﹤0.01% 2861
2024
Q1 		$231K Buy
26,274
+1,835
+8% +$14.9K ﹤0.01% 2953
2023
Q4 		$167K Buy
24,439
+22,231
+1,007% +$182K ﹤0.01% 2889
2023
Q3 		$21.6K Buy
+2,208
New +$17.7K ﹤0.01% 3133
2020
Q2 		– Sell
-15,600
Closed -$81K – 2004
2020
Q1 		$81K Hold
15,600
– – ﹤0.01% 988
2019
Q4 		$115K Buy
+15,600
New +$129K ﹤0.01% 1447

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ULBI Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Ultralife (ULBI) in Q3 2025, closing a stake of 14,910 shares — an estimated $134K sold.

Qube Research & Technologies (QRT) first reported a position in ULBI in Q4 2019 and held it in 7 quarters. The position peaked at $231K in Q1 2024. 63 funds tracked by Wall St. Rank hold ULBI as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Ultralife position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 14,910 Ultralife shares in Q3 2025, an estimated $134K.
  • Qube Research & Technologies (QRT) first reported a position in Ultralife in Q4 2019 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Ultralife position peaked at $231K in Q1 2024.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.